December 05, 2022
Article
Children as young as 12 can now receive tenofovir alafenamide for treatment of chronic hepatitis B virus infection with compensated liver disease, after the US Food and Drug Administration expanded the indication for the drug.
December 02, 2022
A germline-targeting HIV vaccine candidate elicited broadly neutralizing antibodies in 97% of recipients.
November 30, 2022
Resistance to hepatitis C infection may be much greater than previously thought, according to new research by investigators at Trinity College Dublin that revealed associated biological factors.
Alternative strategies to increase immunogenicity of COVID-19 vaccines in immunosuppressed kidney transplant recipients are evaluated in clinical trial.
November 18, 2022
As viral hepatitis is the most common blood-transmitted infection globally, assessing the toll of hepatitis and hepatitis-related conditions is critical.
November 16, 2022
Three posters on the subject were presented at The Liver Meeting and were among the meeting’s key presentation highlights called “Best of the Liver Meeting.”
November 14, 2022
What are the characteristics and demographics of the chronic hepatitis B patients who develop severe outcomes?
November 11, 2022
Looking for the latest developments in infectious disease? Here are the top stories Contagion covered this week.
November 09, 2022
Initially, 28-29% of patients with chronic hepatitis B achieved undetectable virus levels after 24 weeks of treatment with GSK’s bepirovirsen, but this dropped to 9-10% of patients during a phase 2b trial.
November 08, 2022
About a third of veterans who received a letter to get tested for hepatitis C did so, according to a study by the Veterans Affairs Greater Los Angeles Healthcare System.
Broaching the Subject of Antibiotic Allergy Challenges with Patients
Pfizer-BioNTech Asks FDA to Authorize Omicron Bivalent COVID-19 Booster for Children Under 5 Years
Enterococcus Coinfection Enhances C Difficile Infection Severity
FDA Expands Use of Vemlidy to Adolescents with Chronic HBV Infection
